Enhancement of the efficiency of PEI/liposome transfection by magnetofectins formed via electrostatic self-assembly by YongJie Ma et al.
   
 
© The Author(s) 2012. This article is published with open access at Springerlink.com csb.scichina.com   www.springer.com/scp 
                      
*Corresponding author (email: hcgu@sjtu.edu.cn) 
Article 
SPECIAL TOPIC: Multifunctional Nanocarriers for Biomedical Applications November 2012  Vol.57  No.31: 40054011 
 doi: 10.1007/s11434-012-5184-1  
Enhancement of the efficiency of PEI/liposome transfection by 
magnetofectins formed via electrostatic self-assembly 
MA YongJie, WANG XiaoLiang & GU HongChen* 
Nano Biomedical Research Center, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, China 
Received October 10, 2011; accepted February 3, 2012; published online May 15, 2012 
 
One of the major challenges for successful gene therapy is improving the transfection efficiency of non-viral vectors. Magnetic 
nanoparticles (MNPs) have been developed as enhancers of non-viral vehicles. We prepared MNPs and modified them with poly-
ethyleneimine (PEI), citric acid (CA) or carboxylmethyl-dextran (CMD). Both positively charged MNPs (MNPs@PEI) and nega-
tively charged MNPs (MNPs@CA, MNPs@CMD) could spontaneously form transfection complexes (magnetofectins) with 
plasmid DNA and PEI/liposome via electrostatic self-assembly. Our results showed as-prepared magnetofectins apparently en-
hanced PEI/liposome transfection efficiency and/or gene expression level into COS-7 cells with reduced transfection time from 4 h 
to 15 min under a magnetic field in vitro. Meanwhile, the effect of magnetofection was cell line-dependant. These results suggest 
that charged MNPs could improve transfection efficiency for non-viral vectors by simply mixing with them and by exerting a 
magnetic force. Thus such MNPs provide a convenient platform for further applications of gene delivery.  
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Efficient gene delivery remains a challenge for gene therapy. 
Non-viral vectors have the advantages of safety and flexi-
bility over viral vectors [1,2]. However, the transfection 
efficiencies of non-viral gene vectors are generally lower 
than those of viral vectors [3]. In order to improve the 
transfection efficiency of non-viral vectors, a new technol-
ogy termed “magnetofection” has been developed [3–5]. 
With this technology, the complexes of nucleic acids and 
their vectors are combined with MNPs to form “transfection 
ternary complexes” termed magnetofectins [4], which can 
be concentrated to the target cells by a magnetic field. The 
transfection efficiency of certain gene vectors can be en-
hanced while reducing transfection time [5]. 
In order to combine MNPs with non-viral vectors, MNPs 
were coated with PEI [4,5] or cationic liposomes [6]. In fact, 
according to the mechanism study on magnetofection, 
MNPs play the role of driving vector/pDNA complexes to 
cell surface in magnetofection and do not directly affect the 
endocytic uptake mechanism [4]. Magnetofection requires 
MNPs to have sufficient electric potentials at the surface, so 
it is not necessary to modify MNPs with these gene vectors 
according to our previous study [7]. Our experimental evi-
dences indicate that MNPs could not enter nucleus once 
they were internalized by the cells. MNPs would probably 
have to be separated from vector/pDNA complexes after en-    
tering cytoplasm, although detailed mechanism requires fur-
ther investigation. In this study, we aim to further demon-
strate charged MNPs, both positively charged and nega-
tively charged MNPs, can improve transfection efficiency 
for non-viral vectors by simply mixing with them via elec-
trostatic self-assembly.  
In this paper, we introduced the preparation, cytotoxicity 
of magnetofectins as prepared via electrostatic self-assembly, 
and evaluated the performance of these magnetofectins in 
magnetofection as follows: (1) to determine if MNPs@PEI 
can improve PEI reagent transfection; (2) to determine if 
negatively charged MNPs@CA and MNPs@CMD can im-
prove PEI reagent transfection; (3) to determine if charged 
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MNPs can improve Liposome reagent transfection; and (4) 
to compare the transfection effects of magnetofection with 
lipofection in different cell lines. 
1  Materials and methods 
1.1  Materials and equipments 
(1) Materials.  MTT solution and dimethyl sulfoxide (DMSO) 
were from Sigma Aldrich. PEI (25 kD) was from Sigma 
Aldrich. DMEM culture medium (high glucose) and fetal 
calf serum were obtained from Hyclone. Penicillin/strepto-     
mycin and Lipofectamine-2000TM reagent were obtained 
from Invitrogen. Plasmid expressing enhanced green fluores-   
cent protein (pEGFP-C1) was from Clontech and plasmid 
expressing luciferase (pGL3-control vector) was from Pro-    
mega. All other reagents were obtained from Shanghai 
Reagent Company.  
COS-7 (SV 40 transformed kidney cells of African green 
monkey), CHO-K1 (Chinese hamster ovary cells), PC-12 
(clonal rat pheochromocytoma cells) and P815 (mouse 
lymphoblast-like mastocytoma cell line) cell lines were 
purchased from the Cell Bank of Chinese Academy of Sci-
ences.  
(2) Equipments.  The equipments used in this study are 
transmission electron microscopy (TEM, Philips CM-120), 
Zetasizer 2000 (Malvern), magnetic plate (MagnetoFAC-
TOR plate, Chemicell), Multilabel Counter (Victor-3, Per-
kin Elmer) and fluorescent microscope (Leica DMI 3000B). 
1.2  Methods 
(1) Preparation of charged MNPs and magnetofectins.  Charg-    
ed MNPs (MNPs@PEI, MNPs@CA and MNPs@CMD) 
were prepared according to methods described elsewhere [7]. 
Modified MNPs were observed by TEM and their zeta po-
tentials were measured by a Zetasizer.   
To prepare PEI-based magnetofectins, 3 g of plasmid 
expressing enhanced green fluorescent protein or plasmid 
expressing luciferase was suspended in 100 L serum-free 
DMEM buffer followed by adding charged MNPs according 
to mass ratios of MNPs to pDNA (0.1, 0.2, 0.4 or 1.0) and 
incubated at room temperature for 10 min. The 0.26 mg/mL 
PEI solution (1 g of DNA corresponds to 3 nmol of phos-
phate, and 1 L of PEI corresponds to 6 nmol of amine ni-
trogen) was added according to the ratios of amine nitrogen 
of PEI to phosphate of DNA (N/P, 10, 20 or 30) and incu-
bated at room temperature for another 15 min.  
To prepare Liposome-based magnetofectins, standard 
complexes of pEGFP-C1 and Lipofectamine-2000TM rea-
gent were prepared according to the protocol followed by 
mixing with charged MNPs. In liposome-based magne-
tofectins, the M/M of MNPs to pDNA was 0.4.  
About the above magnetofection formulation, 3 g pDNA 
and 1.2 g MNPs were required for each well of a 6-well 
plate, and 0.2 g pDNA and 0.15 g MNPs were required 
for each well of a 96-well plate.  
(2) Cell culture.  COS-7, CHO-K1, PC-12 and P815 cell 
lines were cultured in DMEM supplemented with 10% (v/v) 
fetal bovine serum and 1% penicillin/streptomycin at 37°C 
in a humidified 5% CO2 atmosphere.  
(3) MTT assay.  Cytotoxicity of magnetofectins was 
evaluated by the MTT assay. Cells were seeded in 96-well 
plates (1×105 cells/well) with 200 μL DMEM in each well 
and incubated at 37°C in a humidified atmosphere (5% CO2) 
for 24 h. After removing culture media, a control group was 
treated with 100 L 0.9% physiological saline while the 
experimental groups were treated with 100 L PEI/pDNA 
transfection complexes (0.2 g pDNA, N/P=20) or PEI-based 
magnetofectins. 
Magnetofectins were formed by mixing MNPs@PEI, 
MNPs@CA or MNPs@CMD with pEGFP-C1 (M/M=0.2, 
0.4 or 1.0) followed by mixing with PEI (N/P=20). Accord-
ing to the transfection protocol, COS-7 cells were treated 
with PEI/pDNA transfection complexes for 4 h while they 
were treated with PEI-based magnetofectins for 15 min at a 
magnetic plate. All the cell samples were incubated again 
for another 24 h before 20 L of 5 mg/mL MTT solution in 
PBS was added to each well. The plates were incubated 
once more for 4 h. Then, the MTT-containing media was 
removed and 150 L DMSO was added to dissolve the 
formazan crystals produced from the reduction of MTT by 
viable cells. The optical density was measured by Multila-
bel Counter at 570 nm. The cell viability was calculated by 
normalizing the OD values of the experimental groups to 
that of the control cells.  
(4) Magnetofection.  In order to determine if MNPs@PEI 
could improve PEI reagent transfection, COS-7 cells were 
transfected by MNPs@PEI-based magnetofectins with 
pEGFP-C1 or pGL3-control vector pDNA compared with 
PEI transfection. Magnetofectins were prepared at M/M (0.1, 
0.2, 0.4 or 1.0) and N/P (10, 20 or 30) according to the 
methods described in Section 1.2 (1). 
In order to determine if negatively charged MNPs@CA 
and MNPs@CMD could improve PEI reagent transfection, 
COS-7 cells were transfected with magnetofectins that were 
formed based on the complexing of MNPs@PEI, MNPs@CA, 
or MNPs@CMD with pGL3-control vector pDNA Magne-
tofectins were prepared at M/M (0.2, 0.4 or 1.0) and N/P 20. 
In order to determine if MNPs@PEI, MNPs@CA and 
MNPs@CMD could improve Liposome reagent transfection, 
COS-7 cells were transfected by magnetofectins (M/M=0.4) 
with pEGFP-C1 compared with Lipofectamine-2000TM trans-     
fection.  
In order to compare the transfection efficiency of mag-
netofection with lipofection, CHO-K1, PC-12 and P815 cell 
lines were transfected by MNPs@PEI (M/M=0.4, N/P=20) 
with pEGFP-C1 compared with Lipofectamine-2000TM trans-   
fection. 
During the magnetofection process, magnetofectins were 
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added to serum-free cell culture media and then the cell 
culture plate (6-well plate or 96-well plate) was placed on 
the magnetic plate (200 mT) for 15 min. The media was 
removed from each well and replaced with media supple-
mented with fetal calf serum. Cells were subsequently cul-
tured for 48 h before harvest, and the transfection efficiency 
was determined by counting the percentage of EGFP posi-
tive cells via fluorescent microscope and the levels of lucif-
erase expression were determined via the Multilabel Coun-
ter. All experiments were performed in triplicate. 
2  Results and discussions 
2.1  Characterizations of charged MNPs  
The surface modified particles were from one single batch 
of native particles synthesized by the co-precipitation meth-
ods [8]. The surface modification as characterized by the 
change of the particles’ Zeta potentials, was shown in Fig-
ure 1d. MNPs coated with CA or CMD were negatively 
charged and MNPs coated with PEI were positively charged, 
which were in accordance with the theoretical predictions. 
Furthermore, it was also indicated that the proposed com-
ponents had been successfully coated onto the MNPs. The 
colloidal stability had essential effects on magnetofection 
efficiency. Since the modified MNPs exhibited appreciable 
surface charges, they were consequently well-dispersible in 
water (Figure 1a–c).  
2.2  MTT assays 
To test whether magnetofectins as prepared by three differ-
ent approaches posed any cytotoxicity, at least in the quan-
tity range used for transfection, we evaluated viability of 
COS-7 cells in the presence of these particles. The condi-
tions of the experimental groups in the MTT assay were in 
accordance with the actual transfection protocols. All the 
magnetofectins composed of MNPs@PEI, MNPs@CA or 
MNPs@CMD showed lower cytotoxicity than PEI/DNA 
complexes (Figure 2). In the standard PEI transfection, cells 
would need 4 h of incubation in serum-free and PEI-    
containing media, to achieve considerable transfection effi-
ciency, whereas in the magnetofection groups using charged 
MNPs as transfection enhancers, the required time was 
shortened to only 15 min. This time difference produced 
one of the advantages of using magnetofection for gene  
 
Figure 1  Characterizations of charged MNPs. a, TEM images of MNPs@PEI; b, MNPs@CA; c, MNPs@CMD; d, zeta potentials of modified MNPs 
(mean±SD, n=3). Scale bars are 100 nm. 
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delivery. Moreover, this difference could also probably ex-
plain why the magnetofection did less harm to the cells. 
With shorter exposure, the cells were likely to be less af-
fected. Based on published literature [9,10] and our own data 
(Figure 2), the cytotoxicity was mainly due to PEI. It ap-
peared that the different mass ratios of MNPs to pDNA 
(from 0.2 to 1.0) almost had no influence on the cytotoxicity. 
2.3  MNPs@PEI enhanced PEI gene transfection 
COS-7 cells were transfected by MNPs@PEI-based mag-
netofectins for 15 min on top of the magnetic plate, com-
pared with PEI standard transfection that required 4 h incu-
bation. The transfection enhancement, as determind by the 
luciferase expression efficiencies for pGL3-control vector, 
and by the percentage of GFP-positive cells for pEGFP-C1 
is shown in Figure 3. MNPs@PEI apparently improved PEI 
transfection rate and improved transgene expression level 
with significantly reduced transfection time.  
As Figure 2 showed, the reduced transfection time could 
also reduce the cytotoxicity. On the other hand, the magnet-
ic field could drive the vectors towards the target cells. In 
this manner, the transfection complexes were concentrated 
on the cells surface within a few minutes so that most of the 
cells got in contact with a significant vector dose [11,12]. 
According to our stability studies on the magnetofectins, 
different N/P ratios (10, 20 or 30) did not influence their 
stability and magnetofectins could be sedimented by a 
magnetic force (Figure 3), so that all the magnetofectins 
formed at different N/P acted as enhancers in magnetofec-
tion. Based on the cytotoxic evaluation of magnetofectins, 
different M/M ratios did not apparently influence their cy-
totoxicity (Figure 2). This might be one of the reasons for 
the similar transfection results between magnetofectins formed 
at different M/M ratios. Compared with the effects on trans-
fection efficiency affected by M/M ratios, we consider more 
effects affected by different N/P ratios. However, the rela-
tionship between them needs to be further elucidated. 
2.4  Charged MNPs enhanced PEI and liposome-  
mediated gene transfections 
If charged MNPs have sufficient electric potentials at their 
surfaces, either negative charges or positive charges, they 
could form magnetofectins via electrostatic self-assembly 
with pDNA and PEI. Positively charged MNPs could form 
complexes with negative charged pDNA, while negatively 
charged MNPs could form complexes with positively charged 
PEI. Although the transfection conditions in COS-7 cells 
need to be further optimized, magnetofectins formed at N/P 
20 showed better performance in magnetofection (Figures 4 
and 5). We chose the condition of N/P 20 to determine the 
performances of three kinds of charged MNPs in magne-
tofection.  
Charged MNPs including MNPs@PEI, MNPs@CA and 
MNPs@CMD apparently improved the transgene expres-
sion levels of pGL3-control vector to COS-7 cells compared 
with PEI standard transfection (Figure 4). From the results 
shown in Figure 4, we might infer that the M(MNPs)/M 
(pDNA) ratios do not apparently affect the transfection effi-
ciency, at least in the range we tested. 
We prepared the transfection complexes of pDNA/lip-      
osome according to the protocol followed by the addition of 
the charged MNPs. The different magnetofectins were used 
to transfect COS-7 cells with pEGFP-C1. The difference in 
the level of green fluorescence was obvious: the percentage 
of GFP-positive cells transfected with MNPs@CA- or MNPs-    
@CMD-based magnetofectins for 15 min was much more 
than that transfected by Liposome-2000TM for 15 min or 4 h 
(Figure 5). With the same transfection time period, transfec-
tion rate with MNPs@PEI-based magnetofection was al-
most the same as the one with Lipofectamine transfection  
 
Figure 2  MTT assay to determine cytotoxicity of the transfection complexes. COS-7 cells were incubated with magnetofectins for 15 min or PEI-DNA 
compounds for 4 h, and then processed for MTT assay. In the magnetofectins, the mass ratios of MNPs to pDNA are 0.2, 0.4 or 1.0. Viability of cells was 
shown compared to physiological saline-treated cells (control) (mean±SD, n=3).  
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Figure 3  Quantitative and qualitative analysis of pGL3-control vector and pEGFP-C1 transfection to COS-7 cells with multilabel counter (a, mean±SD, 
n=3); b, fluorescent microscope. Magnetofectins formed by mixing MNPs@PEI with pDNA at different M/M (0.1, 0.2, 0.4 or 1.0) and followed by mixing 
PEI with pDNA at different N/P (10, 20 or 30). PEI transfection was used as a control group. The descriptions of 1–12 in b are listed in the lower table. 
 
Figure 4  Charged MNPs enhanced transgene expression levels in COS-7 
cells compared with PEI standard transfection (N/P=20, mean±SD, n=3) 
Relative luciferase activity (RLU/mg of total protein) was used to compare 
the transfection efficiency.  
(Figure 5b,c). Despite the different surface charges on 
MNPs, we prepared liposome-based magnetofectins at the 
same mass ratios and N/P ratios. Liposome is widely used 
for transfection, but what makes the transfection inconven-
ient is that the culture media usually need be changed after 
4 h incubation. Furthermore, it is difficult for liposome to be 
used in vivo. In our experiments, we tested liposome-based 
transfection with 15 min incubation as well, and found this 
shortened incubation did not apparently alter transfection 
efficiency. Surprisingly, with the addition of MNPs@-     
PEI, MNPs@CA and MNPs@CMD into liposome-based 
transfection system (Figure 5c–e) with 15 min incubation, 
the transfection efficiency as indicated by percentage of 
GFP + cells, increased significantly (Figure 5c–e vs. a,b). It 
seemed that MNPs@CA, MNPs@CMD could enhance lip-
osome transfection effects more than MNPs@PEI (Figure 
5d,e vs. c). The above results might suggest liposome trans-
fection could be more convenient and highly efficient by 
adding magnetic enhancers and might mean the possibility 
of remotely controlled vector targeting in vivo. This fact 
also implies that the transfection efficiency might be im-
proved if MNPs modified with enough charge on the sur-
face are added to other non-viral/pDNA complexes at cer-
tain M/M and N/P ratios, and a magnetic force is exerted.  
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Figure 5  Charged MNPs enhanced GFP-positive cell-percentages of COS-7 cells compared with liposome transfection. a, Lipofectamine-2000TM transfec-
tion for 4 h; b, Lipofectamine-2000TM transfection for 15 min; c–e, MNPs@PEI, MNPs@CA or MNPs@CMD based liposome-magnetofection for 15 min. 
A–E was the bright phase of a–e, respectively.  
2.5  Cell line-dependant magnetofection 
As the MNPs@PEI could serve as enhancers to improve the 
PEI-reagent transfection rate, which is also a very conven-
ient system, we then evaluated the differences of transfec-
tion rate in different cell lines. The results showed the final 
transfection efficiency of magnetofection was apparently  
different in the three cell lines, which suggested the magne-
tofection efficiency was cell line-dependant (Figure 6). In 
general, liposome reagent is superior to PEI reagent (used 
alone) owning to the high toxicity of PEI. We then experi-
mented using MNPs as transfection enhancers to improve 
the transfection efficiency for PEI reagent, in comparison 
with the liposome reagent. PEI-magnetofection was superi-
or to Lipofectamine-2000TM transfection in CHO-K1 cells  
 
Figure 6  Using MNPs@PEI as enhancers of PEI transfection to transfect CHO-K1 cells a, PC-12 cells b and P815 cells c, respectively, and using Lipofec-
tamine-2000TM reagent to transfect CHO-K1 d, PC-12 e and P815 cells f, respectively. 
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(Figure 6a,d), but the results were on the opposite in PC-12 
cells (Figure 6b,e), and there were almost no cells trans-
fected in the suspended cell-P815 by using either methods 
(Figure 6c,f). The transfection rate and the gene expression 
level could be improved by magnetofection, but the final 
transfection level achieved also depended on the original 
transfection reagent and the cell lines. Based on the mecha-
nism of magnetofection in general that: (1) the magnetic 
field itself does not alter the uptake mechanism of magne-
tofectins; (2) the magnetic forces lead to an accelerated 
sedimentation of magnetofectins on the cell surface; and (3) 
do not directly affect the endocytic uptake mechanism [8], 
and from our results shown in Figure 6, the magnetofection 
has its limitation to overcome the bottle-neck problems to 
transfect the hard-transfected cells, such as the primary cells, 
the nerve cells and the suspended cells.  
3  Conclusions 
In summary, we have shown that magnetofectins are easy to 
be prepared by mixing charged MNPs with pDNA and vec-
tors via electrostatic self-assembly. The as-formed magne-
tofectins are stable enough to meet the needs of magnetofec-
tion and apparently improve transfection rates and transgene 
expression level in COS-7 cells compared to standard PEI 
and liposome transfections. Higher transfection rates and 
transgene expression levels are achievable within short pro-
cessing time, resulting in measurable advantages including 
reduction of cytotoxicity and convenience of the operation. 
Our transfection study in COS-7 cells would contribute to 
the design of magnetofection protocols. Both positively and 
negatively charged MNPs provide a convenient platform of 
making magnetofectins with comparable transfection effi-
ciency. Taken together, we demonstrate that magnetofectins 
formed by self-assmebly of charged MNPs, pDNA and PEI  
could improve non-viral vector transfection, which could be 
used for targeted gene delivery in further applications.   
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